PBIGF
PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. (PBIGF)
$13
About PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. (PBIGF)
Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. It is a drug repurposing company which seeks to find new uses for old drugs. The company was founded by Paul John Rennie on May 2, 2014 and is headquartered in Melbourne, Australia.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.38
52 Week Low
$0.11
Market cap
52.1M
Dividend yield
0.00%
Volume
--
Avg. volume
1,026
P/E ratio
-4.57
PARADIGM BIOPHARMACEUTICL by Paradigm Biopharmaceuticals Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.38
52 Week Low
$0.11
Market cap
52.1M
Dividend yield
0.00%
Volume
--
Avg. volume
1,026
P/E ratio
-4.57